Singulex Collaborating with Novartis, Opening European Facility | GenomeWeb
NEW YORK (GenomeWeb News) – Alameda, Calif.-based Singulex announced yesterday that it is collaborating with the Swiss pharmaceutical company Novartis and that it has opened a new facility in Paris to serve European collaborators.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.